The DASH diet was originally designed for hypertension, this antihypertensive effect was attributed mainly to sodium antagonism from high potassium foods and improved insulin sensitivity from dietary fiber, but its beneficial effects on metabolic syndrome, diabetes, and obesity have made it an important nonpharmacologic intervention for comprehensive metabolic management (9–14). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.